Staurosporine inhibits the soluble and membrane-bound protein tyrosine kinases of human neutrophils
- 31 July 1991
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 178 (2), 423-429
- https://doi.org/10.1016/0006-291x(91)90124-p
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Utility of staurosporine in uncovering differences in the signal transduction pathways for superoxide production in neutrophilsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- Tyrosine phosphorylation in human neutrophilBiochemical and Biophysical Research Communications, 1989
- Human neutrophils contain distinct cytosolic and particulate tyrosine kinase activities: possible role in neutrophil activationBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- 1,2‐Diacylglycerol accumulation in human neutrophils does not correlate with respiratory burst activationFEBS Letters, 1989
- Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potein inhibitor of insulin receptor than IGF-I receptorBiochemical and Biophysical Research Communications, 1988
- Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase IINature, 1988
- Use of tyrosine‐containing polymers to characterize the substrate specificity of insulin and other hormone‐stimulated tyrosine kinasesEuropean Journal of Biochemistry, 1985
- Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase CBiochemistry, 1984
- Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadateBiochemical and Biophysical Research Communications, 1982
- Cytochalasin E diminishes the lag phase in the release of superoxide by human neutrophilsBiochemical and Biophysical Research Communications, 1982